02:26:31 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2025-02-14 Bokslutskommuniké 2024
2024-11-08 Kvartalsrapport 2024-Q3
2024-08-23 Kvartalsrapport 2024-Q2
2024-05-10 Ordinarie utdelning ORTI A 0.00 SEK
2024-05-10 Ordinarie utdelning ORTI B 0.00 SEK
2024-05-08 Kvartalsrapport 2024-Q1
2024-05-08 Årsstämma 2024
2024-02-16 Bokslutskommuniké 2023
2023-11-10 Kvartalsrapport 2023-Q3
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-05 Ordinarie utdelning ORTI A 0.00 SEK
2023-05-05 Ordinarie utdelning ORTI B 0.00 SEK
2023-05-04 Kvartalsrapport 2023-Q1
2023-05-04 Årsstämma 2023
2023-02-17 Bokslutskommuniké 2022
2022-11-11 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-05-06 Ordinarie utdelning ORTI A 0.00 SEK
2022-05-06 Ordinarie utdelning ORTI B 0.00 SEK
2022-05-05 Årsstämma 2022
2022-04-27 Kvartalsrapport 2022-Q1
2022-02-16 Bokslutskommuniké 2021
2021-11-12 Kvartalsrapport 2021-Q3
2021-08-20 Kvartalsrapport 2021-Q2
2021-05-06 Ordinarie utdelning ORTI B 0.00 SEK
2021-05-06 Ordinarie utdelning ORTI A 0.00 SEK
2021-05-05 Årsstämma 2021
2021-04-27 Kvartalsrapport 2021-Q1
2021-02-16 Bokslutskommuniké 2020
2020-11-10 Kvartalsrapport 2020-Q3
2020-08-21 Kvartalsrapport 2020-Q2
2020-05-13 Ordinarie utdelning ORTI A 0.00 SEK
2020-05-13 Ordinarie utdelning ORTI B 0.00 SEK
2020-05-04 Årsstämma 2020
2020-04-23 Kvartalsrapport 2020-Q1
2020-02-18 Årsstämma 1
2020-02-13 Bokslutskommuniké 2019
2020-02-13 Årsstämma 1
2019-10-25 Årsstämma 1
2019-08-22 Kvartalsrapport 2019-Q2
2019-05-07 Ordinarie utdelning ORTI A 0.00 SEK
2019-05-07 Ordinarie utdelning ORTI B 0.00 SEK
2019-05-06 Årsstämma 2019
2019-05-03 Kvartalsrapport 2019-Q1
2019-02-18 Extra Bolagsstämma 2019
2019-02-13 Bokslutskommuniké 2018
2018-11-20 Kvartalsrapport 2018-Q3
2018-08-24 Kvartalsrapport 2018-Q2
2018-05-04 Ordinarie utdelning ORTI B 0.00 SEK
2018-05-04 Ordinarie utdelning ORTI A 0.00 SEK
2018-05-03 Årsstämma 2018
2018-04-30 Kvartalsrapport 2018-Q1
2018-02-08 Bokslutskommuniké 2017
2017-11-21 Kvartalsrapport 2017-Q3
2017-08-22 Kvartalsrapport 2017-Q2
2017-05-12 Extra Bolagsstämma 2017
2017-05-02 Ordinarie utdelning ORTI B 0.00 SEK
2017-05-02 Kvartalsrapport 2017-Q1
2017-05-02 Ordinarie utdelning ORTI A 0.00 SEK
2017-04-28 Årsstämma 2017
2017-02-10 Bokslutskommuniké 2016
2016-10-24 Kvartalsrapport 2016-Q3
2016-07-13 Kvartalsrapport 2016-Q2
2016-05-09 Årsstämma 2016
2016-05-02 Kvartalsrapport 2016-Q1
2016-04-30 Ordinarie utdelning ORTI B 0.00 SEK
2016-04-30 Ordinarie utdelning ORTI A 0.00 SEK
2016-02-10 Bokslutskommuniké 2015
2015-10-20 Kvartalsrapport 2015-Q3
2015-07-13 Kvartalsrapport 2015-Q2
2015-04-30 Ordinarie utdelning ORTI B 0.00 SEK
2015-04-30 Ordinarie utdelning ORTI A 0.00 SEK
2015-04-29 Årsstämma 2015
2015-04-29 Kvartalsrapport 2015-Q1
2015-02-17 Bokslutskommuniké 2014
2014-10-27 Kvartalsrapport 2014-Q3
2014-07-11 Kvartalsrapport 2014-Q2
2014-04-30 Ordinarie utdelning ORTI A 0.00 SEK
2014-04-30 Ordinarie utdelning ORTI B 0.00 SEK
2014-04-29 Årsstämma 2014
2014-04-29 Kvartalsrapport 2014-Q1
2014-02-07 Bokslutskommuniké 2013
2013-10-18 Kvartalsrapport 2013-Q3
2013-07-12 Kvartalsrapport 2013-Q2
2013-04-30 Kvartalsrapport 2013-Q1
2013-04-22 Ordinarie utdelning ORTI A 0.00 SEK
2013-04-22 Ordinarie utdelning ORTI B 0.00 SEK
2013-04-19 Årsstämma 2013
2013-02-08 Bokslutskommuniké 2012
2012-10-18 Kvartalsrapport 2012-Q3
2012-07-12 Kvartalsrapport 2012-Q2
2012-05-04 Ordinarie utdelning ORTI B 0.00 SEK
2012-05-04 Ordinarie utdelning ORTI A 0.00 SEK
2012-05-03 Årsstämma 2012
2012-04-20 Kvartalsrapport 2012-Q1
2012-02-22 Bokslutskommuniké 2011
2011-10-14 Kvartalsrapport 2011-Q3
2011-08-12 Kvartalsrapport 2011-Q2
2011-05-31 Extra Bolagsstämma 2010
2011-05-05 Ordinarie utdelning ORTI A 0.00 SEK
2011-05-05 Ordinarie utdelning ORTI B 0.00 SEK
2011-05-04 Årsstämma 2011
2011-04-15 Kvartalsrapport 2011-Q1
2011-02-18 Bokslutskommuniké 2010
2010-10-14 Kvartalsrapport 2010-Q3
2010-08-12 Kvartalsrapport 2010-Q2
2010-05-04 Ordinarie utdelning ORTI A 0.00 SEK
2010-05-04 Ordinarie utdelning ORTI B 0.00 SEK
2010-05-03 Årsstämma 2010
2010-04-22 Kvartalsrapport 2010-Q1
2010-02-19 Bokslutskommuniké 2009
2009-11-12 Kvartalsrapport 2009-Q3
2009-08-14 Kvartalsrapport 2009-Q2
2009-05-07 Ordinarie utdelning ORTI A 0.00 SEK
2009-05-07 Ordinarie utdelning ORTI B 0.00 SEK
2009-05-06 Kvartalsrapport 2009-Q1
2009-05-06 Årsstämma 1
1998-04-23 Split ORTI A 1:2

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Ortivus är verksamt inom hälsovårdssektorn. Bolaget är specialiserade inom utvecklingen av mobila lösningar för sjukvården. Tjänsterna innefattar exempelvis övervaknings- och kommunikationslösningar som vidare används inom beslut- och stödsystem. Idag vidaresäljs lösningarna under flertalet varumärken med vardera affärsinriktning. Störst verksamhet innehas inom Norden, samt Europa. Ortivus etablerades under 1985 och har sitt huvudkontor i Danderyd.
2023-12-01 08:30:00

Ortivus AB and HealthCare Software (HCS) have entered into a collaboration through an exclusive distributor agreement that encompasses the United Kingdom and Ireland. This strategic agreement provides Ortivus with the opportunity to offer HCS' Controlled Drug Management solution. This solution ensures secure end-to-end management of controlled drugs in the prehospital care setting.

We are pleased to announce that Ortivus has joined forces with the Australia-based digital health company HealthCare Software (HCS). Through this partnership, Ortivus will serve as the local representative and distributor for HCS’ Controlled Drug Management solution, purpose-built for the safe and accurate management of medications in the Ambulance and Emergency Services settings.
 
The agreement is exclusive and applies to the United Kingdom and Ireland. In addition to delivering the product, Ortivus will also provide comprehensive service and support.
 
“We are delighted to enter into this partnership with HCS! The Controlled Drug Management solution is cutting-edge, with functionality that significantly enhances the critical management of controlled drugs in prehospital care. This agreement further strengthens Ortivus’ product portfolio, and we eagerly anticipate introducing this innovative technology to our primary markets.” – Says Elias Obaid, Global Sales Manager at Ortivus.
 
Rich Metcalfe, CEO of HealthCare Software said, “HCS is delighted to be partnering with Ortivus, a leading provider of solutions to ambulance services across the world. I’m excited to be working with the team from Ortivus to bring our Controlled Drug Management solution to the UK and Ireland. Ortivus and HCS share deep domain knowledge in pre-Hospital care and our solution nicely complements their product suite”.
 
HCS is based in Australia, where Ortivus since 2021 is represented by the local partner, Corvanta.
 
About HealthCare Software
HealthCare Software (HCS) is an Australian Digital Health company with nearly 20 years’ experience in delivering exceptional solutions to solve complex healthcare problems. Founded by a clinical pharmacist in 2005, HCS solutions are used in public health settings where accurate and efficient management of medications are valued for clinical and patient safety. HCS solutions are used across more than 200 hospitals by in excess of 30,000 primary care providers.
 
HCS’ Controlled Drug Management solution is purpose-built for Ambulance and Emergency Services with a view to safe and secure end-to-end management of controlled drugs in the station, field and in transit. 
 
Used by 100s of paramedics daily, HCS’ Controlled Drug Management ensures Ambulance services can be confident that controlled drugs can be tracked, incidents managed, and audits performed through a simple interface delivered from the cloud and accessible on any device at any time.
 
Controlled Drug Management can be integrated into systems that support standards-based integration such as HL7 and FHIR and is routinely integrated to Active Directory, Ambulance electronic patient record and Rostering solutions.